# ASTEROID (NCT03446547)

> Ablative STEreotactic RadiOtherapy wIth Durvalumab (MEDI4736)

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT03446547
- Phase: PHASE2
- Status: COMPLETED
- Sponsor: Vastra Gotaland Region
- Conditions: NSCLC, Stage I
- Interventions: Durvalumab
- Enrollment: 106
- Primary outcome: TTP

## Preliminary discovery

Commentary in our index that names this trial so far. Final coverage is set when the report is built.

- X threads: 2
- Bluesky threads: 1

## Order

Focused, $750, price fixed at order: https://www.erudio.com/contact?report=asteroid-nct03446547